Anti-lung cancer drug, Iressa approved to sell.
Iressa was first approved in Japan on July 5, 2002 and treated with more than 23,500 patients up to Jan. this year, show...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
